http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105055420-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ad4e1d9a7f860720557c9f32a750cc0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
filingDate 2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f337b9594860cec82099f86d300a08ff
publicationDate 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105055420-A
titleOfInvention Medicine cefamandole nafate composition for treating bacterial infection
abstract The invention relates to a cefamandole nafate medicine composition for treating bacterial infection and belongs to the technical field of medicines. The composition is composed of cefamandole nafate and sodium dihydrogen phosphate; cefamandole nafate is a crystal and an X-ray powder diffraction pattern obtained through measurement of Cu-K(alpha) ray is shown in the graph I. The novel crystal form of cefamandole provided by the invention is different from the crystal form structure in the prior art, through experimental verification, the fact that the novel crystal form compound is high in purity, good in mobility and stability, low in polymer content, low in hygroscopicity, and safe and reliable during clinical application is found, powder-injection prepared from the novel crystal form compound is good in stability, good in stability after being combined with a solvent, and extremely low in content of insoluble particles and is particularly suitable for being applied clinically.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105566351-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105596346-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105596346-B
priorityDate 2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24196325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447574277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451127818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449599971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449847384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553

Total number of triples: 38.